FDA rejects two China-developed cancer drugs

Bio Pharma Dive

The regulator cited concerns around single-country trials in turning back Hutchmed's pancreatic cancer treatment, while manufacturing issues held up Junshi and Coherus' throat cancer medicine

Visual system brain development implicated in infants who develop autism

Scienmag

Social & Behavioral Science autism brain develop development implicated infants system visual

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

FDA, NIH initiative aims to speed development of drugs for ALS, other brain diseases

Bio Pharma Dive

The public-private partnership plans to bring together scientific experts, private entities and patient groups to better understand certain neurodegenerative disorders and find new treatments

MD Anderson launches new spinout to develop radiopharmaceuticals

Bio Pharma Dive

The joint venture with Radiopharm Theranostics is pursuing a field of research that’s seen a string of recent deals and investments by large drugmakers

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Bain Capital backs new biotech startup developing oral asthma drug

Bio Pharma Dive

Areteia Therapeutics will receive $350 million from Bain and others to advance a drug that was previously licensed to Biogen for testing as an ALS treatment

Supporting multi-audience communication in all stages of drug development

Bio Pharma Dive

Biopharmaceutical companies have ongoing and extensive needs for print and digital communications throughout the drug development life cycle that can benefit from a single-source vendor

Merck stops coronavirus vaccine development in surprise setback

Bio Pharma Dive

The drugmaker, one of the largest vaccine developers globally, won't move forward with either of two candidates it's been testing after disappointing data in early trials

How preschoolers’ brains develop self-control

Scienmag

Biology brains develop preschoolers selfcontrolAs their brain regions linked to self-control mature, preschoolers improve in their ability to stop themselves from doing something, according to new research published in JNeurosci. Credit: Berger et al.,

Cancer increases the risk of developing diabetes

Scienmag

Cancer patients are at a greater risk for developing diabetes, according to a new study by the Steno Diabetes Center Copenhagen, Rigshospitalet, and the University of Copenhagen. The study also concludes that cancer patients who develop diabetes die sooner than survivors without diabetes.

2nd NSCLC Drug Development Summit

Pharma Phorum

The 2nd NSCLC Drug Development Summit returns for its second year to unite biopharma and academic leaders during an exciting era of personalized medicine. Improve your drug development rationale across all lines of NSCLC and address challenges when moving therapies forward.

Arcturus announces $63m award from US government to support development of self-amplifying mRNA vaccine

BioPharma Reporter

from the Biomedical Advanced Research and Development Authority (BARDA): allowing the company to expand its current influenza vaccine program to include development of a pandemic influenza vaccine based on its proprietary self-amplifying mRNA platform. Bio Developments

In the News: November 2021 Regulatory and Development Updates

Camargo

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. 505(b)(2) Development Blog In the News Pediatrics Regulatory Strategy & Submissions

Yet another gene therapy developer turns to layoffs

Bio Pharma Dive

Taysha Gene Therapies is narrowing its research efforts and cutting around 35% of its workforce, the latest in a series of layoffs announced by makers of genetic medicines

Al Sandrock takes on CEO role at gene therapy developer

Bio Pharma Dive

The well-known researcher and Biogen alumnus has agreed to take the top spot at Voyager Therapeutics, which, last spring, underwent a "strategic shift" that saw its then-CEO and research head depart

In the News: August 2021 Regulatory and Development Updates

Camargo

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. In the News: August 2021 Regulatory and Development Updates.

Vaccine Developers of the Year: BioNTech and Moderna

Bio Pharma Dive

Defying expectations, BioNTech and Moderna each designed and developed highly effective coronavirus shots far faster than previously considered possible

Vertex, Verve team up to develop a gene editing drug for liver disease

Bio Pharma Dive

The deal, which is worth $60 million upfront, broadens Vertex’s reach into gene editing and expands Verve’s research beyond heart disease

Apple Developer Academy opens in Pohang

Scienmag

Korea’s first Apple Developer Academy held its first class online on March 14. The Apple Developer Academy is an education program for developers in the making. Social & Behavioral Science Academy apple developer opens Pohang

CureVac increases focus on cancer vaccine development

BioPharma Reporter

A partnership with myNEO represents the first step in CureVacâs targeted expansion of its mRNA approach for the development of cancer vaccines, says the company. Bio Developments

FDA and NIH partner for neurodegenerative disease treatment development

Pharmaceutical Technology

The US Food and Drug Administration (FDA) and the US National Institutes of Health (NIH) have unveiled a public-private partnership (PPP) to understand and develop treatments for neurodegenerative diseases.

IDRx, a new biotech startup, raises $122M to develop better cancer drug combinations

Bio Pharma Dive

Founded by serial entrepreneur Alexis Borisy, the company comes equipped with two experimental medicines it licensed from Merck KGaA and Blueprint Medicines

Novel immunotherapy mechanism suppresses breast cancer development

Scienmag

Biology breast cancer development immunotherapy mechanism suppresses

FDA seeking more consistency from cell, gene therapy developers, top official says

Bio Pharma Dive

A number of drugmakers have recently faced development delays after the FDA's asked for more information on how they measure the potency of their products

Researchers develop 3D-printed jelly

Scienmag

Biology Biomedical/Environmental/Chemical Engineering Materials Research/Development Technology/Engineering/Computer Science

Antibody shows promise for developing hantavirus treatment

Scienmag

Based on their initial results, the antibody appears to be a promising candidate for developing a “pan-hantavirus” therapy to protect against outbreaks caused by […]. Biology antibody developing hantavirus promise shows treatment

Embryonic development and cancer cell growth

Scienmag

Researchers of the University of Barcelona and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) have shown in a study with lung cancer cell lines that the same molecular signals that control the embryonic development can also control the harmfulness of cancer cells.

West makes minority investment in vaccine & biologics delivery tech developer

BioPharma Reporter

Bio DevelopmentsWest Pharmaceutical Services has made an investment in Latch Medical, a Dublin-based company working on next-generation vaccine and biologics delivery technology.

Amgen partners with Arrakis to develop drugs aimed at RNA

Bio Pharma Dive

Arrakis, a specialist in designing oral drugs that target RNA, will receive $75 million under the deal, which could be worth "several billion dollars" more

RNA 216

Researchers develop a paper-thin loudspeaker

Scienmag

MIT engineers have developed a paper-thin loudspeaker that can turn any surface into an active audio source. Credit: Image: Felice Frankel MIT engineers have developed a paper-thin loudspeaker that can turn any surface into an active audio source.

Book examines the future of executive development

Scienmag

Toronto – Executive development programs have entered a period of rapid transformation, driven by digital disruption and a widening gap between the skills that participants and their organizations demand and those provided by their executive programs.

Ultrasonic tech to develop safer railway track lubrication measurement system

Scienmag

THE University of Huddersfield has forged a partnership with an innovative technology business to work with Network Rail on developing a safer and more reliable track lubrication measurement system.

Scientists develop new biomimetic formulation for treating glioblastoma

Scienmag

Cancer biomimetic develop formulation glioblastoma scientists treatingGlioblastoma multiforme (GBM) is an aggressive brain cancer with a poor prognosis and few treatment options. New and effective approaches for GBM treatment are therefore urgently needed.

Gilead partners with a cancer biotech, seeking to develop an HIV immunotherapy

Bio Pharma Dive

Gritstone Oncology, known for its cancer research, is drawing attention in infectious disease, signing a deal with Gilead two weeks after announcing plans to develop a coronavirus vaccine

Messenger RNA technology shows promise for developing infectious disease therapeutics

Scienmag

Army scientists and industry partners were among the first to demonstrate that messenger RNA (mRNA)—the technology recently used in COVID-19 vaccines and others—could also be used to develop treatments for infectious diseases.

RNA 71

Bias in artificial intelligence impacts drug development: AiCure

Outsourcing Pharma

According to an expert from the clinical insights company, prejudice in AI can impact patient outcomes as well as the ability to develop effective treatments. Clinical Development

Study identifies unique underlying molecular factors driving melanoma development

Scienmag

COLUMBUS, Ohio – A new study reveals important molecular information that could help scientists develop more effective treatment and prevention strategies for a difficult-to-treat form of melanoma skin cancer.

UCLA researchers develop novel microscopic picoshell particles

Scienmag

Biology develop microscopic particles picoshell researchers UCLAProduction of high-energy fats by microalgae may provide a sustainable, renewable energy source that can help tackle climate change.

Parental type 1 diabetes can affect children’s cognitive development

Scienmag

Cognitive development in children could be affected regardless of which biological parent has type 1 diabetes, according to research publishing April 19th in the open access journal PLOS Medicine. Biology affect childrens cognitive development Diabetes Parental type

Development of magnetic cooling materials that enable efficient hydrogen liquefaction

Scienmag

National Institute for Materials Science (NIMS), Tohoku University and Japan Synchrotron Radiation Research Institute (JASRI) have developed a series of Er(Ho)Co2-based magnetic cooling alloys that can be used to efficiently cool hydrogen from 77 K to 20 K: its liquefaction temperature.

Development of stretchable and printable free-form lithium-ion batteries

Scienmag

A Korean research team has developed a soft, mechanically deformable, and stretchable lithium battery which can be used in the development of wearable devices, and examined the battery’s feasibility by printing them on clothing surfaces.

A crowning achievement in understanding head development

Scienmag

Biology Achievement crowning development UnderstandingCranial neural crest cells, or CNCCs, contribute to many more body parts than their humble name suggests.

Modular super-enhancer controls retinal development

Scienmag

Jude Children’s Research Hospital studied the Vsx2 super-enhancer and its role in the development of the retina. Chemistry AND Physics controls development Modular retinal superenhancerEnhancers are regions of DNA that do not code for proteins, but control how genes are expressed.

DNA 71